Sign up with:
"The current share price is $0.40 per share which means the downside to 0 is limited"
Apparently, losing 100% of your investment qualifies as a limited loss in the eyes of the author.
More risk factors:
1) RXI will be delisted from NASDAQ in May if the share price fails to get to $1.
One possible solution would be to do a reverse split.
RXI has previously done a 1-for-30 reverse split with devastating consequences for shareholders
2) If RXI is such a good investment, why has there been no insider buying since April 2015?
And the CEO is the ONLY insider making any purchases of note in the past.
Article Comments
Latest Comments
RXi Pharmaceuticals: Keeping A Large Focus On Shareholder Value Creation In 2016
"The current share price is $0.40 per share which means the downside to 0 is limited"
Apparently, losing 100% of your investment qualifies as a limited loss in the eyes of the author.
More risk factors:
1) RXI will be delisted from NASDAQ in May if the share price fails to get to $1.
One possible solution would be to do a reverse split.
RXI has previously done a 1-for-30 reverse split with devastating consequences for shareholders
2) If RXI is such a good investment, why has there been no insider buying since April 2015?
And the CEO is the ONLY insider making any purchases of note in the past.